Table 1 Baseline characteristics of the study participants (N = 199)
NEC | Case group (n = 93) | Control group (n = 106) | Standardize diff | P-value |
|---|---|---|---|---|
Gestational age, weeks (Mean ± SD) | 32.74 ± 2.52 | 32.46 ± 2.75 | 0.10 (− 0.17–0.38) | 0.466 |
Birth weight, g (Mean ± SD) | 1733.83 ± 504.75 | 1793.36 ± 581.09 | 0.11 (− 0.17–0.39) | 0.444 |
Age, hours (Median[Q1-Q3]) | 0.42 (0.35–0.87) | 0.48 (0.36–0.94) | 0.00 (− 0.28–0.28) | 0.993 |
SEX (n, %) |  |  | 0.18 (− 0.10–0.46) | 0.209 |
Male | 43 (46.24%) | 59 (55.14%) | Â | Â |
Female | 50 (53.76%) | 47 (44.86%) | Â | Â |
NLR (Mean ± SD) | 2.10 ± 1.40 | 1.70 ± 0.50 | 0.40(0.10–0.70) | 0.008 |
CRP, mg/L, (Median[Q1-Q3]) | 4.89 (1.26–18.00) | 3.30 (2.33–6.13) | 0.48 (0.20–0.76) |  < 0.001 |
VD (n, %) |  |  | 0.08 (− 0.20–0.36) | 0.577 |
No | 71 (76.34%) | 78 (72.90%) | Â | Â |
Yes | 22 (23.66%) | 28 (27.10%) | Â | Â |
CA (n, %) |  |  | 0.02 (− 0.26–0.29) | 0.907 |
No | 54 (58.06%) | 63 (58.88%) | Â | Â |
Yes | 39 (41.94%) | 43 (41.12%) | Â | Â |
PE (n, %) |  |  | 0.38 (0.10–0.66) | 0.008 |
No | 40 (43.01%) | 66 (61.68%) | Â | Â |
Yes | 53 (56.99%) | 40 (38.32%) | Â | Â |
GDM (n, %) |  |  | 0.27 (− 0.01–0.55) | 0.061 |
No | 46 (49.46%) | 67 (62.62%) | Â | Â |
Yes | 47 (50.54%) | 39 (37.38%) | Â | Â |